|Articles|February 1, 2011
- BioPharm International-02-01-2011
- Volume 24
- Issue 2
BioPharm International, February 2011 Issue (PDF)
The Quality Product Steward Model
Advertisement
Articles in this issue
about 15 years ago
The Quality Product Steward Model: The Genentech Approachabout 15 years ago
An Economic Comparison of Three Cell Culture Techniquesabout 15 years ago
The Powerful Lesson of the GSK–Whistleblower Caseabout 15 years ago
Trends Toward Standardizationabout 15 years ago
Congress to Scrutinize FDA Rules, Research Policiesabout 15 years ago
What a Piece of Work is PharmaNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
